Black Friday Sale - Ends Soon!
-35% Off Everything
ABT

Abbott Laboratories (ABT)

Last Price$118.8(0.2%)
Market Cap$196.8B
Financial profile score
5/10
LTM Revenue
$40.7B
+1.0% YoY
LTM Net Income
$5.6B
-1.3% YoY
LTM Free Cash Flow
$5,654.0M
+14.8% YoY
Net Debt
$7,767.0M
Short-term financial position
1.7x
Current Assets / Current Liabilities

ABT Income statement

Crunching data... Almost there!

ABT Balance sheet

Crunching data... Almost there!

ABT Key balance sheet metrics

Crunching data... Almost there!

ABT Cash flow statement

Crunching data... Almost there!

ABT Key cash flow statement metrics

Crunching data... Almost there!

Discover more ABT fundamentals

Stock picking tips. Ultimate guide 2024
Discover the secrets to successful stock picking in 2024! We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.

FAQ

What are Abbott Laboratories (ABT) Key Income Statement Metrics?

As of today, Abbott Laboratories last 12-month Revenue is $40.7B , EBITDA is $8.4B and Net Income is $5.6B , based on the financial report for Jun 30, 2024 (Q2 2024).

What are Abbott Laboratories (ABT) Key Balance Sheet Metrics?

As of today, Abbott Laboratories Total Assets are $73.0B and Total Liabilities are $33.5B , based on the financial report for Jun 30, 2024 (Q2 2024).

What are Abbott Laboratories (ABT) Key Cash Flow Statement Metrics?

As of today, Abbott Laboratories last 12-month Cash Flow from Operating Activities is $1,960.0M, Cash Flow from Investing Activities is ($453.0M) and Cash Flow from Financing Activities is ($791.0M), based on the financial report for Jun 30, 2024 (Q2 2024).

What is Abbott Laboratories (ABT) Free Cash Flow?

As of today, Abbott Laboratories last 12-month Free Cash Flow is $5,654.0M , based on the financial report for Jun 30, 2024 (Q2 2024).